LY-402913

• Description :

  LY-402913 is a selective multidrug resistance protein (MRP1) inhibitor[1].

• UNSPSC :

  12352005

• Target :

  P-glycoprotein

• Type :

  Reference compound

• Related Pathways :

  Membrane Transporter/Ion Channel

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Cancer; Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/ly-402913.html

• Purity :

  99.86

• Solubility :

  DMSO : 50 mg/mL (ultrasonic; warming)

• Smiles :

  O=C(CC1=CC=CC(N2C(C3=C(C4=C2C=CC=C4Cl)ON=C3C)=O)=C1)NC5=CC(OC)=C(C(OC)=C5)OC

• Molecular Formula :

  C28H24ClN3O6

• Molecular Weight :

  533.96

• References & Citations :

  [1]Bryan H Norman, et al. Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1) . Bioorg Med Chem Lett. 2002 Mar 25;12 (6) :883-6.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C, 3 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [334970-65-9]